H.C. Wainwright Upgrades Dicerna Pharmaceuticals (DRNA) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Dicerna Pharma (DRNA) Appoints J. Kevin Buchi & Cynthia Smith to Board
August 17, 2018 5:59 AM EDTDicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) today announced the appointments of J. Kevin Buchi, former chief executive officer of Cephalon, Inc., and TetraLogic Pharmaceuticals Corp., and Cynthia Smith, former chief commercial officer of ZS Pharma, Inc., to its board of directors. The appointments are effective immediately and increase the size of... More



